Factors of early infancy and recurrent use of antibiotic therapy.

AIM: To analyse the role of early infant-related, parent-related, family functioning and social relation factors during the infant's first 3 mo of life and their associations with later recurrent treatments with antibiotics. METHODS: In an unselected population-based study, parents expecting their first child were followed from pregnancy until the infant was 18 mo of age. Informed consent to participate was obtained from 1443 women expecting their first child and their spouses. The parents of 817 children reported the number of preceding antibiotic treatments at two times (when the child was 9 and 18 mo old). The outcome measure was the number of antibiotic treatments (options: none, 1-5, > or = 6). The factors associated with later use of antibiotics were collected during the first 3 mo of the infant's life. The variable factors included infant-related, parent-related, family functioning and social relation factors. RESULTS: The final regression analysis showed the potent factors associated with recurrent use of antibiotics: male gender (OR 2.8, 95% CI: 1.6-4.8), frequent physician consultations in early infancy (OR 3.1, 95% CI: 1.8-5.3) and the father's need for outside support (OR 2.2, 95% CI: 1.3-3.8). CONCLUSIONS: In addition to early infant-related medical factors, family factors may be associated with frequent medical consultations and the decision to administer antibiotics to the infant. In the prevention of antibiotic overuse, social and psychological factors should be considered.

Pregnancy and childbirth-related factors associated with recurrent antibiotic use in infants.

AIM: To determine the reasons for the possible overuse of antibiotics by investigating whether family-related medical, behavioural, emotional, and social risk factors during the mother's pregnancy and childbirth are associated with subsequent recurrent antibiotic therapy of infants. METHODS: Subject selection was based on stratified randomized cluster sampling. A total of 1443 women (91%) and their spouses expecting their first child gave informed consent to participate and 1287 infants were born. The parents of 817/1025 infants (80%) reported the number of courses of antibiotic therapy the child had received at the ages of 9 and 18 mo. The outcome measure was the number of courses of antibiotic therapy (none/1-5/=6) given during the first 18 mo of life. The explanatory variables included family-related factors during the pregnancy and immediately after childbirth. RESULTS: In the final multivariate stepwise analysis, parents' long-term illnesses were associated with recurrent antibiotic medication. CONCLUSIONS: Parents with long-term illnesses need special guidance and support from the beginning of the mother's pregnancy in order to minimize the subsequent risk for recurrent antibiotic therapy of their infants. Preventive healthcare workers should be aware of the effects of these factors on parental guidance.